Correlation Between Black Diamond and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Blueprint Medicines Corp, you can compare the effects of market volatilities on Black Diamond and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Blueprint Medicines.
Diversification Opportunities for Black Diamond and Blueprint Medicines
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Black and Blueprint is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Black Diamond i.e., Black Diamond and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Black Diamond and Blueprint Medicines
Given the investment horizon of 90 days Black Diamond Therapeutics is expected to under-perform the Blueprint Medicines. In addition to that, Black Diamond is 2.06 times more volatile than Blueprint Medicines Corp. It trades about -0.33 of its total potential returns per unit of risk. Blueprint Medicines Corp is currently generating about -0.09 per unit of volatility. If you would invest 9,478 in Blueprint Medicines Corp on July 22, 2024 and sell it today you would lose (878.00) from holding Blueprint Medicines Corp or give up 9.26% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Black Diamond Therapeutics vs. Blueprint Medicines Corp
Performance |
Timeline |
Black Diamond Therap |
Blueprint Medicines Corp |
Black Diamond and Blueprint Medicines Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Black Diamond and Blueprint Medicines
The main advantage of trading using opposite Black Diamond and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.Black Diamond vs. Agilent Technologies | Black Diamond vs. 23Andme Holding Co | Black Diamond vs. DiaMedica Therapeutics | Black Diamond vs. Valneva SE ADR |
Blueprint Medicines vs. Agilent Technologies | Blueprint Medicines vs. 23Andme Holding Co | Blueprint Medicines vs. DiaMedica Therapeutics | Blueprint Medicines vs. Valneva SE ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |